Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins

  • STATUS
    Recruiting
  • End date
    Jul 14, 2025
  • participants needed
    340
  • sponsor
    University of Colorado, Denver
Updated on 19 February 2024
immunosuppressive agents
arthritis
autoimmune disease

Summary

The study is designed to learn more about the causes of rheumatoid arthritis (RA). People who get RA have elevated protein markers called autoantibodies in their blood years before initial symptoms of arthritis. The goal of this study is to learn more about how autoantibodies in RA might be related to inflammation in the lungs.

Description

The Specific Aims of This Study Are As Follows:

  1. Identify whether sputum anti-CCP predicts incident RA
  2. Determine the effect of inflammatory cytokines on the induction of NETosis in sputum neutrophils
  3. Determine the role of sputum macrophage phagocytosis in NET clearance <br> The knowledge gained from this study will improve the overall understanding of the development of RA. It is anticipated that these findings will improve the field's understanding of how best to screen for RA risk and target RA prevention. This study could support future lung-targeted prevention strategies for RA that could avoid the administration of systemic toxic therapies. Such potential prevention interventions could be implemented in subjects at risk for RA in order to prevent the irreversible joint damage that can occur in the later stages of clinically-apparent RA.

Details
Condition Rheumatoid Arthritis, Rheumatoid Arthritis
Age 18years - 100years
Treatment N/A (Observational Study)
Clinical Study IdentifierNCT04474392
SponsorUniversity of Colorado, Denver
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

have been met
If interested, please take a few minutes to complete the screening
questionnaire for this study opportunity. You may open the survey in your web
browser by clicking the link below
<https://is.gd/SPAROscreen>
If the link above does not work, try copying the link below into your web
browser
<https://redcap.ucdenver.edu/surveys/?s=3WM8WH3WKK>

Exclusion Criteria

Currently pregnant or planning to become pregnant during the sample collection period of the study
Exacerbation of underlying obstructive lung disease within the past 1 month
Known FEV1 <1 liter
Oxygen requirement >2 liters at rest
Participants with health acuity or behavioral health concerns leaving them unable to participate in the current research
Note: If a subject temporarily does not meet inclusion criteria but is
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study AnnotationsStudy Notes

Notes added here are public and can be viewed by anyone. Notes added here are only available to you and those who you share with.

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.